The influence of ofloxacin and enoxacin on the metabolic pathways of theophylline in healthy volunteers
- 17 Downloads
The pharmacokinetic parameters of theophylline and its major metabolites were measured in two healthy volunteers, after the administration of theophylline alone and during co-medication with ofloxacin, 200 mg twice daily, or enoxacin, 200 mg twice daily. During enoxacin co-medication, elimination half-lives of theophylline increased from 8.7 h to 17.4 h and from 6.1 h to 12.3 h, respectively. As the renal clearance of theophylline did not change, the decreased elimination of theophylline during enoxacin co-medication must result from a reduced metabolic clearance. Enoxacin co-medication caused a clearly decreased formation of the metabolitesI-methyluric acid and 3-methylxanthine, formed by N-demethylation, whereas the C-8 oxidation of theophylline was less influenced compared to the blank. Enoxacin's interference with the theophylline disposition is predominantly based on the inhibition of the microsomal N-demethylation. Ofloxacin co-medication did not induce a change in the plasma parameters or renal excretion of theophylline and its metabolites.
KeywordsDrug interactions Enoxacin Metabolism Ofloxacin Pharmacokinetics Theophylline
Unable to display preview. Download preview PDF.
- 2.Hendeles L, Massanari M, Weinberg M. Theophylline. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied pharmacokinetcs. Spokane: Applied Therapeutics Inc., 1986:1105–88.Google Scholar
- 4.Thomson RD, Nagasawa HT, Jenne JW. Determination of theophylline and its metabolites in human urine and serum by high-pressure liquid chromatography. J Lab Clin Med 1974;85:584–93.Google Scholar
- 5.Yesair DW, Branfman AR, Callahan MM. Human disposition and some biochemical aspects of methylxanthines. In: Spiller GA, ed. The methylxanthine beverages and foods: chemistry, consumption and health aspects. New York: Alan R. Liss Inc., 1984:215–33.Google Scholar
- 6.Wijnands WJA, Van Herwaarden CLA, Vree TB. Enoxacin raises plasma theophylline concentrations. Lancet 1984;2:108–9.Google Scholar
- 10.Raoof S, Wollschlager C, Khan F. Serum theophylline levels are increased by ciprofloxacin (Bay 9867), a new quinolone antibiotic. Chest 1985;88:32.Google Scholar
- 12.Logamann C, Ohnhaus EE. Enoxacin, a differential inhibitor of the microsomal liver enzyme system in man. Abstract 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, USA, 1987.Google Scholar
- 13.Okazaki O, Miyazaki K, Tachizawa H. Lack of effect of ofloxacin on theophylline pharmacokinetics in rats. Chemotherapy 1987;502.Google Scholar
- 19.Tang-Liu DDS, Williams RL, Riegelman S. Disposition of caffeine and its metabolites in man. J Pharmacol Exp Ther 1983;24:180–5.Google Scholar
- 21.Rosenberry KR, Defusco CJ, Mansmann HC, McGeady SJ. Reduced theophylline half-life induced by carbamazepine therapy. J Pediatr 1983;702:472–4.Google Scholar
- 24.Grygiel JJ, Miners JO, Drew R, Brikett DJ. Differential effects of cimetidine on theophylline metabolic pathways. Eur J Pharmacol 1984;26:335–40.Google Scholar